INTERNATIONAL PATENT: DRAGUSTINOVIS, MARIA ESTHER FILES APPLICATION FOR "DEVELOPMENT OF FORMULATIONS FOR THE MANAGEMENT AND ANTIVIRAL, IMMUNOMODULATORY AND ANTI-INFLAMMATORY TREATMENT OF THE NEW SARS-COV-2 INFECTION AND THE ASSOCIATED DISEASE, COVID-19 AND ITS VARIANTS, FORMULATED FROM GLYCYRRHIZIC ACID SALT AND THE DERIVATIVES THEREOF"

GENEVA, April 29 -- DRAGUSTINOVIS, Maria Esther (2da cda de tezoquipa, No. 171, col. club de golf Mexico, Tlalpan.Ciudad de Mexico, 14620) filed a patent application (PCT/MX2024/050055) for "DEVELOPMENT OF FORMULATIONS FOR THE MANAGEMENT AND ANTIVIRAL, IMMUNOMODULATORY AND ANTI-INFLAMMATORY TREATMENT OF THE NEW SARS-COV-2 INFECTION AND THE ASSOCIATED DISEASE, COVID-19, AND ITS VARIANTS, FORMULATED FROM GLYCYRRHIZIC ACID SALT AND THE DERIVATIVES THEREOF" on Oct 14, 2024. With publication no. WO/2025/084921, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Or...